Ginsenoside Rg1 treatment alleviates renal fibrosis by inhibiting the NOX4–MAPK pathway in T2DM mice

Ginsenoside Rg1 treatment alleviates renal fibrosis by inhibiting the NOX4–MAPK pathway in T2DM mice

AbstractDiabetic kidney disease (DKD) is a severe complication of type 2 diabetes mellitus (T2DM). However, the pathogenesis of DKD remains unclear, and effective treatment strategies are still lacking. Ginsenoside Rg1 (Rg1) has been reported to improve DKD, but the mechanism is unclear. NADPH oxida...

Full description

Bibliographic Details
Main Authors: Pengmin Ji, Qifeng Shi, Yan Liu, Min Han, Yong Su, Ran Sun, Huimin Zhou, Weizu Li, Weiping Li
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Renal Failure
Subjects:
Type 2 diabetes mellitus
diabetic kidney disease
ginsenoside Rg1
NOX4
MAPK
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2023.2197075

Internet

https://www.tandfonline.com/doi/10.1080/0886022X.2023.2197075

Similar Items